Thomas Woiwode, Director at CRISPR Therapeutics AG (CRSP), sold 443,104 shares at $50.11 ($22.2M) on 2018-04-26, disclosed to the SEC on 2018-04-30.
Open-market sale of $22.2M CRSP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.11 | 14,086 | $706K | 3.2% |
| 2 | $50.11 | 14,086 | $706K | 3.2% |
| 3 | $50.11 | 185,075 | $9.3M | 41.8% |
| 4 | $50.11 | 185,075 | $9.3M | 41.8% |
| 5 | $50.12 | 5,430 | $272K | 1.2% |
| 6 | $50.12 | 5,430 |
| $272K |
| 1.2% |
| 7 | $50.12 | 6,019 | $302K | 1.4% |
| 8 | $50.12 | 6,019 | $302K | 1.4% |
| 9 | $50.01 | 333 | $17K | 0.1% |
| 10 | $50.02 | 10,236 | $512K | 2.3% |
| 11 | $50.02 | 10,236 | $512K | 2.3% |
| 12 | $50.03 | 779 | $39K | 0.2% |
| 13 | $50.08 | 300 | $15K | 0.1% |
| Total | $50.11 avg | 443,104 | $22.2M | 100% |
| Filing → |
| ALGS | BUY | 2020-10-20 | $3.0M | — | Filing → |
| PASG | BUY | 2020-03-03 | $4.0M | — | Filing → |
| CRSP | SELL | 2018-05-17 | $2.6M | — | Filing → |